NO20006455D0 - Testosteron-derivat - Google Patents

Testosteron-derivat

Info

Publication number: NO20006455D0
Authority: NO; Norway
Prior art keywords: testosterone; compound; testosterone derivative; good; oxoundecyl
Prior art date: 1998-06-19

Application number

NO20006455A

Other languages

English (en)

Other versions

NO316518B1 (no

NO20006455L (no

Inventor

Dirk Leysen

Hendrikus Adrianus Anton Voort

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-19

Filing date

2000-12-18

Publication date

2000-12-18

2000-12-18 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2000-12-18 Publication of NO20006455D0 publication Critical patent/NO20006455D0/no

2000-12-18 Publication of NO20006455L publication Critical patent/NO20006455L/no

2004-02-02 Publication of NO316518B1 publication Critical patent/NO316518B1/no

Links

150000003515 testosterones Chemical class 0.000 title abstract 2
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 abstract 1
WRLOOHHQBLTCLM-QKLCDPPYSA-N [(7r,8r,9s,10r,13s,14s,17s)-7,13-dimethyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl] undecanoate Chemical compound C([C@H]1C)C2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC2 WRLOOHHQBLTCLM-QKLCDPPYSA-N 0.000 abstract 1
239000003098 androgen Substances 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
229960003604 testosterone Drugs 0.000 abstract 1
ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)
Percussion Or Vibration Massage (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20006455A 1998-06-19 2000-12-18 Testosteron-derivat NO316518B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98202052		1998-06-19
PCT/EP1999/004102 WO1999067271A1 (en)	1998-06-19	1999-06-14	Testosterone derivative

Publications (3)

Publication Number	Publication Date
NO20006455D0 true NO20006455D0 (no)	2000-12-18
NO20006455L NO20006455L (no)	2000-12-18
NO316518B1 NO316518B1 (no)	2004-02-02

Family

ID=8233831

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006455A NO316518B1 (no)	1998-06-19	2000-12-18	Testosteron-derivat

Country Status (25)

Country	Link
US (3)	US6437158B1 (no)
EP (1)	EP1087986B1 (no)
JP (1)	JP2002518514A (no)
KR (1)	KR100596649B1 (no)
CN (1)	CN1172949C (no)
AT (1)	ATE215961T1 (no)
AU (1)	AU756739B2 (no)
BR (1)	BR9911344A (no)
CA (1)	CA2333985C (no)
CZ (1)	CZ293319B6 (no)
DE (1)	DE69901250T2 (no)
DK (1)	DK1087986T3 (no)
ES (1)	ES2175989T3 (no)
HU (1)	HUP0102274A3 (no)
ID (1)	ID27260A (no)
IL (1)	IL139689A (no)
NO (1)	NO316518B1 (no)
NZ (1)	NZ508299A (no)
PL (1)	PL191285B1 (no)
PT (1)	PT1087986E (no)
RU (1)	RU2216546C2 (no)
SK (1)	SK282796B6 (no)
TR (1)	TR200003743T2 (no)
WO (1)	WO1999067271A1 (no)
ZA (1)	ZA200006813B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6756366B1 (en) *	1999-04-06	2004-06-29	Akzo Nobel N.V.	Orally active androgens
HRP20030060A2 (en) *	2000-07-28	2004-06-30	Akzo Nobel Nv	16alpha-methyl or ethyl substituted estrogens
JP3774888B2 (ja) *	2001-11-28	2006-05-17	日本化薬株式会社	ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
TW200404552A (en) *	2002-05-30	2004-04-01	Akzo Nobel Nv	Self administered contraception
TW200400041A (en) *	2002-05-30	2004-01-01	Akzo Nobel Nv	Use of new etonogestrel esters
TW200403065A (en)	2002-05-30	2004-03-01	Akzo Nobel Nv	New etonogestrel esters
GB0304927D0 (en)	2003-03-04	2003-04-09	Resolution Chemicals Ltd	Process for the production of tibolone
JO2505B1 (en) *	2003-03-14	2009-10-05	باير شيرنغ فارما اكتنجيسيلشافت	Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
JO2492B1 (en)	2003-04-28	2009-10-05	شيرينج ايه جي	A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
PE20050677A1 (es)	2003-12-22	2005-10-04	Akzo Nobel Nv	Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru)	2004-09-08	2010-03-25	Н.В. Органон	15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP1879382B1 (en)	2006-07-10	2017-09-06	Samsung Electronics Co., Ltd.	Multi-screen display apparatus and method for digital broadcast receiver
WO2008101030A1 (en) *	2007-02-13	2008-08-21	The Regents Of The University Of California	Methods for amplifying steroid hormone effects
US20090018107A1 (en) *	2007-07-13	2009-01-15	Oral Delivery Technology Ltd.	Novel composition to increase muscle strength
US20090017107A1 (en) *	2007-07-13	2009-01-15	Oral Delivery Technology Ltd.	Novel composition to increase libido
US20100303937A1 (en) *	2009-06-01	2010-12-02	Michael Farber	Novel composition to increase testosterone levels
CN102558267A (zh) *	2012-01-13	2012-07-11	宜城市共同药业有限公司	庚酸睾酮的制备方法
EP2833944A4 (en)	2012-04-06	2016-05-25	Antares Pharma Inc	ADMINISTRATION OF TESTOSTERONE COMPOSITIONS BY NEEDLE-SUPPORTED NOZZLE INJECTION
PT2953667T (pt) *	2013-02-11	2020-01-28	Antares Pharma Inc	Dispositivo de injeção a jato auxiliado por agulha tendo força de gatilho reduzida

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5342834A (en) *	1989-04-07	1994-08-30	The Population Council, Inc.	Method for androgen supplementation

1999
- 1999-06-14 RU RU2001101892/04A patent/RU2216546C2/ru not_active IP Right Cessation
- 1999-06-14 DK DK99929208T patent/DK1087986T3/da active
- 1999-06-14 CN CNB998075175A patent/CN1172949C/zh not_active Expired - Fee Related
- 1999-06-14 BR BR9911344-9A patent/BR9911344A/pt not_active Application Discontinuation
- 1999-06-14 NZ NZ508299A patent/NZ508299A/xx unknown
- 1999-06-14 TR TR2000/03743T patent/TR200003743T2/xx unknown
- 1999-06-14 WO PCT/EP1999/004102 patent/WO1999067271A1/en not_active Ceased
- 1999-06-14 AU AU46101/99A patent/AU756739B2/en not_active Ceased
- 1999-06-14 CA CA002333985A patent/CA2333985C/en not_active Expired - Fee Related
- 1999-06-14 CZ CZ20004779A patent/CZ293319B6/cs not_active IP Right Cessation
- 1999-06-14 ID IDW20002632A patent/ID27260A/id unknown
- 1999-06-14 HU HU0102274A patent/HUP0102274A3/hu unknown
- 1999-06-14 IL IL13968999A patent/IL139689A/en not_active IP Right Cessation
- 1999-06-14 KR KR1020007014182A patent/KR100596649B1/ko not_active Expired - Fee Related
- 1999-06-14 SK SK1940-2000A patent/SK282796B6/sk not_active IP Right Cessation
- 1999-06-14 JP JP2000555922A patent/JP2002518514A/ja active Pending
- 1999-06-14 EP EP99929208A patent/EP1087986B1/en not_active Expired - Lifetime
- 1999-06-14 US US09/719,927 patent/US6437158B1/en not_active Expired - Fee Related
- 1999-06-14 DE DE69901250T patent/DE69901250T2/de not_active Expired - Fee Related
- 1999-06-14 PL PL344987A patent/PL191285B1/pl not_active IP Right Cessation
- 1999-06-14 AT AT99929208T patent/ATE215961T1/de not_active IP Right Cessation
- 1999-06-14 PT PT99929208T patent/PT1087986E/pt unknown
- 1999-06-14 ES ES99929208T patent/ES2175989T3/es not_active Expired - Lifetime
2000
- 2000-11-21 ZA ZA200006813A patent/ZA200006813B/en unknown
- 2000-12-18 NO NO20006455A patent/NO316518B1/no unknown
2002
- 2002-06-21 US US10/177,989 patent/US20040033999A1/en not_active Abandoned
2004
- 2004-10-13 US US10/964,076 patent/US6989378B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BR9911344A (pt)	2001-03-13
CA2333985A1 (en)	1999-12-29
JP2002518514A (ja)	2002-06-25
TR200003743T2 (tr)	2001-07-23
US20050153949A1 (en)	2005-07-14
CN1172949C (zh)	2004-10-27
NZ508299A (en)	2003-04-29
DE69901250T2 (de)	2002-10-17
DK1087986T3 (da)	2002-06-17
SK282796B6 (sk)	2002-12-03
US6989378B2 (en)	2006-01-24
ID27260A (id)	2001-03-22
US20040033999A1 (en)	2004-02-19
KR100596649B1 (ko)	2006-07-06
NO316518B1 (no)	2004-02-02
ZA200006813B (en)	2002-02-21
HK1034263A1 (en)	2001-10-19
DE69901250D1 (de)	2002-05-16
US6437158B1 (en)	2002-08-20
IL139689A0 (en)	2002-02-10
CZ20004779A3 (en)	2001-06-13
HUP0102274A2 (hu)	2001-12-28
WO1999067271A1 (en)	1999-12-29
CA2333985C (en)	2007-04-10
CZ293319B6 (cs)	2004-04-14
AU4610199A (en)	2000-01-10
EP1087986A1 (en)	2001-04-04
ES2175989T3 (es)	2002-11-16
AU756739B2 (en)	2003-01-23
RU2216546C2 (ru)	2003-11-20
KR20010052850A (ko)	2001-06-25
CN1305488A (zh)	2001-07-25
SK19402000A3 (sk)	2001-07-10
PL191285B1 (pl)	2006-04-28
NO20006455L (no)	2000-12-18
EP1087986B1 (en)	2002-04-10
IL139689A (en)	2004-09-27
PL344987A1 (en)	2001-11-19
PT1087986E (pt)	2002-08-30
ATE215961T1 (de)	2002-04-15
HUP0102274A3 (en)	2002-08-28

Publication	Publication Date	Title
DK1087986T3 (da)	2002-06-17	Testosteronderivat
ES2194446T3 (es)	2003-11-16	Derivados de bibiclooctano utilizados como plastificantes.
AU2002211216A1 (en)	2002-04-02	Substituted aminopropoxyaryl derivatives useful as agonists for lxr
EA200300337A1 (ru)	2003-08-28	Полиарилкарбоксамиды, применимые в качестве агентов, снижающих содержание липидов
FR2733244B1 (fr)	1999-07-30	Systeme de stabilisants a base de derives de polyalkylpiperidine
MXPA05009985A (es)	2005-11-04	Ligandos de receptores de canabinoides.
ES2134847T3 (es)	1999-10-16	Derivados de taxol.
BR0109703A (pt)	2003-02-04	Derivados de piperazina
CO5231161A1 (es)	2002-12-27	4-aminopicolinatos y su uso como herbicidas
PL378577A1 (pl)	2006-05-02	Pochodne estrogenu jako inhibitory sulfatazy steroidowej
NO20014925L (no)	2001-12-13	Farmasöytiske forbindelser
ATE278661T1 (de)	2004-10-15	Anthranilsäurederivate
DE60135748D1 (de)	2008-10-23	Synthese zyklischerverbindungen
BRPI0412636A (pt)	2006-09-26	imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer
DE69617909D1 (de)	2002-01-24	2-substituierte vitamin-d3-derivate
KR960037677A (ko)	1996-11-19	4-인돌릴피페라지닐 유도체
TR200400293T4 (tr)	2004-04-21	9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.
WO2000040589A3 (en)	2000-11-23	Novel derivatives from the class of oleandomycin
AR025073A1 (es)	2002-11-06	Proceso para la preparacion de compuestos de 1,3-dicarbonilo acilados
EP1270567A4 (en)	2004-09-08	PYRAZOLINE DERIVATIVES OR TETRAHYDROPYRAZOLINE DERIVATIVES AND THEIR MEDICAL USE
BR0013100A (pt)	2002-04-30	Processo para a preparação de um composto de 2-arilvinil alquil éter
MY120189A (en)	2005-09-30	Sultam and sultone derived oxazolidinones
ECSP992934A (es)	1999-06-11	Procedimiento mejorado para la preparacion de derivados de norbenzomorfano, valiosos farmaceuticamente
MX9704976A (es)	1998-01-31	Derivados de 1,2,3-benzotiadiazol.
IT1318465B1 (it)	2003-08-25	Processo per la preparazione di decaidro-2a, 4a,6a,8a-tetraazaciclopent(fg)acenaftilene e derivati funzionalizzati.